A high-resolution crystal structure of SARS-CoV-2 coronavirus 3CL hydrolase (Mpro) was announced after the outbreak of COVID-19 in the world [80], and human coronaviruses (HCoVs) have been treated as severe pathogens in respiratory tract infections.